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Cofactor-mediated conformational control in the
bifunctional kinase/RNase Ire1
Alexei V Korennykh1,2,5*, Pascal F Egea2,6, Andrei A Korostelev3, Janet Finer-Moore2, Robert M Stroud2,
Chao Zhang1,4, Kevan M Shokat1,4 and Peter Walter1,2
Abstract
Background: Ire1 is a signal transduction protein in the endoplasmic reticulum (ER) membrane that serves to
adjust the protein-folding capacity of the ER according to the needs of the cell. Ire1 signals, in a transcriptional
program, the unfolded protein response (UPR) via the coordinated action of its protein kinase and RNase domains.
In this study, we investigated how the binding of cofactors to the kinase domain of Ire1 modulates its RNase
activity.
Results: Our results suggest that the kinase domain of Ire1 initially binds cofactors without activation of the RNase
domain. RNase is activated upon a subsequent conformational rearrangement of Ire1 governed by the chemical
properties of bound cofactors. The conformational step can be selectively inhibited by chemical perturbations of
cofactors. Substitution of a single oxygen atom in the terminal b-phosphate group of a potent cofactor ADP by
sulfur results in ADPbS, a cofactor that binds to Ire1 as well as to ADP but does not activate RNase. RNase activity
can be rescued by thiophilic metal ions such as Mn2+ and Cd2+, revealing a functional metal ion-phosphate
interaction which controls the conformation and RNase activity of the Ire1 ADP complex. Mutagenesis of the
kinase domain suggests that this rearrangement involves movement of the aC-helix, which is generally conserved
among protein kinases. Using X-ray crystallography, we show that oligomerization of Ire1 is sufficient for placing
the aC-helix in the active, cofactor-bound-like conformation, even in the absence of cofactors.
Conclusions: Our structural and biochemical evidence converges on a model that the cofactor-induced
conformational change in Ire1 is coupled to oligomerization of the receptor, which, in turn, activates RNase. The
data reveal that cofactor-Ire1 interactions occur in two independent steps: binding of a cofactor to Ire1 and
subsequent rearrangement of Ire1 resulting in its self-association. The pronounced allosteric effect of cofactors on
protein-protein interactions involving Ire1’s kinase domain suggests that protein kinases and pseudokinases
encoded in metazoan genomes may use ATP pocket-binding ligands similarly to exert signaling roles other than
phosphoryl transfer.
Background
The unfolded protein response (UPR) is an intracellular
signaling pathway that provides homeostatic feedback
regulation between the endoplasmic reticulum (ER) and
the gene expression program in the nucleus. To this
end, the UPR senses the conditions inside the ER,
detecting an imbalance between newly synthesized pro-
tein influx and the protein-folding capacity in the ER
lumen, and activates a corrective response. When
activated, the UPR drives a broad transcriptional pro-
gram that adjusts the abundance of the ER [1].
The primary signal transduction device in the UPR is
an ER membrane-resident sensor of misfolded proteins,
Ire1. Ire1 is conserved from yeast to mammalian cells
[2-4]. According to one model, unfolded proteins act as
ligands that bind directly to the Ire1 luminal domain
[5,6]. Another model posits an indirect mode of activa-
tion in which the ER-luminal chaperone BiP plays a cen-
tral role [7]. Both views converge on the concept that
oligomerization of the Ire1-luminal domain is crucial for
signal propagation across the membrane. Oligomeriza-
tion of Ire1’s luminal domains leads to a local increase
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in the concentration of Ire1’s cytoplasmic kinase and
RNase domains, which are tethered to the ER-luminal
domain through a transmembrane segment. Recent
structural insights suggest that oligomerization activates
the cytoplasmic modules by their cooperative assembly
into an ordered oligomer [8]. The kinase domains
undergo trans-autophosphorylation, which installs phos-
phate-mediated salt bridges between adjacent Ire1
monomers to stabilize the oligomer. The resulting juxta-
position of Ire1’s RNase domains assembles and stabi-
lizes the RNase active site [8,9]. Ire1 then initiates the
unconventional splicing of HAC1 (yeast) or XBP1
(metazoan) mRNA by cleaving either mRNA at two
conserved sites to excise an intron [8,10]. Transfer RNA
ligase completes the mRNA splicing reaction in yeast
[4], and an as yet unknown enzyme ligates the exons in
metazoans. Intron removal allows the production of the
UPR transcription activators Hac1 and XBP1, respec-
tively. The transcription factors upregulate UPR target
genes, closing a feedback loop that adjusts the ER’s pro-
tein-folding capacity according to need.
The kinase domain of Ire1 is structurally and bio-
chemically similar to that of other protein kinases,
including cSrc [11], epidermal growth factor receptor
(EGFR) [12], PKR [13], GCN2 [14], cyclin-dependent
kinase 2 (CDK2) [9], Aurora [15], cAMP [16] and mito-
gen-activated protein kinase kinase 1 [17] (Additional
file 1, Figures S1 and S2). Notably, binding of nucleo-
tides and synthetic ligands to the kinase domain of Ire1
allosterically activates the Ire1 RNase [8,18]. Ire1’s
RNase activity provides a built-in reporter of kinase con-
formation, establishing Ire1 as a unique model in which
conformational properties of a kinase can be studied
separately from the phosphoryl transfer step by using a
sensitive and quantitative enzymatic readout.
ADP serves as a cofactor [10] which stimulates RNase
activity of Saccharomyces cerevisiae Ire1 in vitro by
approximately 200-fold [8]. It has been proposed that
ADP and other ATP pocket ligands stabilize Ire1 in a
conformation that forms oligomers [8]. As protein
kinases related to Ire1 can assume two globally different
conformational states, commonly referred to as “inac-
tive” and “active” [12], Ire1 monomers were thought to
exist in an inactive conformation and cofactors were
thought to stabilize the active conformation via occu-
pancy of the ATP pocket [18]. This simple model, how-
ever, cannot explain the paradoxical observation that
ADP has been reported to be a better cofactor than the
bulkier ATP [10]. Binding of ATP to the ATP pocket
does not fully trigger the RNase-activating conforma-
tional change in Ire1, arguing against the model that
ATP pocket occupancy is sufficient to lock Ire1 into the
active conformation and to activate RNase. In the pre-
sent study, we carried out a quantitative analysis of Ire1
oligomerization and RNase activation properties with a
series of cofactors to resolve this conundrum and to
glean insights into the allosteric mechanism by which
cofactors control the activity of Ire1 RNase.
Results
RNase activity quantitatively correlates with Ire1
oligomerization
We observed previously [8] that Ire1 RNase is activated
upon high-order oligomerization of Ire1’s kinase/RNase
domains (Figure 1a). At sufficiently high concentrations,
a cytosolic portion of Ire1 (Ire1KR32) forms large-scale
oligomers that scatter visible light and display high
RNase activity [8]. Ire1KR32 contains Ire1’s cytoplasmic
kinase and RNase domains, is autophosphorylated as
isolated from the Escherichia coli expression host and
bears an N-terminal 32-aa extension derived from the
linker that connects the Ire1 kinase and transmembrane
domains. This N-terminal extension is important for
optimal oligomerization and RNase activity of Ire1 [8].
As Ire1KR32 oligomerization resulted in cloudy solu-
tions visible to the naked eye, we explored whether sam-
ple transparency could be used to evaluate the oligomer
formation quantitatively. We found that turbidity of
Ire1KR32 solutions measured as an optical density at
500 nm (OD500) indeed provides a reliable, quantitative
metric of oligomerization (Figure 1b).
As a function of enzyme concentration, the OD500 of
Ire1KR32 solutions increased cooperatively by approxi-
mately two orders of magnitude in both the absence
and presence of the activating cofactor ADP Mg (Figure
1b, diamonds and circles, respectively). Observed Hill
coefficients (n = 3 for Ire1 ADP Mg and n = 8 for apo-
Ire1) were in close agreement with those determined in
an enzymatic assay that monitors Ire1’s RNase activity
(n = 3.5 for Ire1 KR32 ADP Mg and n = 8 for apo-
Ire1KR32 [8]) (Figure 1a). In the presence of the ADP
Mg cofactor, both OD500 and RNase profiles shift simi-
larly toward lower Ire1KR32 concentrations, which,
together with similar Hill coefficients, indicates that
both assays monitor the same physical phenomenon:
high-order Ire1 oligomerization.
As shown in an overlay of the OD500 and RNase mea-
surements (Additional file 1, Figure S3), both assays are
indeed superimposable. OD500 was below the detection
limit at Ire1KR32 concentrations that already displayed
activated RNase, indicating that active Ire1KR32 oligo-
mers at these concentrations are too sparse to result in
detectable turbidity. By contrast, OD500 values continued
to rise after RNase activity reached a kinetic plateau due
to the onset of a saturating regime k2, as the oligomer
concentration exceeded the Km for RNA binding [19].
The RNase and OD500 readouts therefore complement
one another and allow monitoring of the log-linear
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oligomerization over a broader range of Ire1 concentra-
tions than either assay in isolation. The RNase activity
provides a more sensitive measurement and detects oli-
gomers at concentrations several orders of magnitude
smaller than those detectable by OD500 readings.
Recombinantly expressed Ire1KR32 used in these stu-
dies contains approximately 20 phosphates [8]. We
showed previously that removal of these phosphates by
mutagenesis of the kinase active site shifted the activa-
tion profile to higher Ire1KR32 concentrations [8]. To
further verify that the RNase-based readout of
oligomerization and the more direct readout based on
OD500 absorbance are in agreement, we measured the
concentration dependence of an unphosphorylated var-
iant of Ire1KR32, Ire1KR32(D797N, K799N). This dou-
ble-mutant carries mutations of residues that are
required for g-phosphate coordination and catalysis of
phosphotransfer but otherwise do not disrupt nucleotide
coordination at the ATP pocket. Recombinantly
expressed Ire1KR32(D797N, K799N) is entirely unpho-
sphorylated as established by mass-spectrometry, and
phosphotransfer-inactive [20]. As shown in Figures 1c
c                                                                     d
a   b
Figure 1 Linking RNase activity and high-order oligomerization of Ire1 kinase/RNase. (a) Cooperative activation of Ire1 RNase with and
without 2 mmol ADP Mg [8]. The dashed line marks the standard assay condition at 3 μmol Ire1KR32. (b) Opacity at 500 nm versus
concentration of Ire1KR32 with and without 2 mmol ADP Mg. (c) RNase activation profiles for Ire1KR32, Ire1KR32(D797N, K799N) bearing a
catalytically disabled, unphosphorylated kinase domain, and for Ire1KR32(E715K). Reactions were conducted as in (a) in the presence of 2 mmol
ADP Mg. (d) OD500 response versus concentration of Ire1KR32, Ire1KR32(D797N, K799N) and Ire1KR32(E715K). Assays were conducted as in (b) in
the presence of 2 mmol ADP Mg.
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and 1d, both RNase activity and OD500 profiles were
shifted to higher enzyme concentrations for Ire1KR32
(D797N, K799N). Note that the data include the charac-
terization of an additional Ire1 mutant Ire1KR32
(E715K), which also exhibited a consistent shift in both
assays and is discussed below.
Therefore, both RNase and OD500 readouts report
robustly on cofactor addition (Figures 1a and 1b) and
perturbations due to mutations in Ire1 (Figures 1c and
1d). We show below that the equivalency between the
optical and enzymatic readouts also extends to all other
variables tested, such as chemical substitution in the
ADP cofactor and addition of thiophilic metal ions in
the presence of an ADP isostere, ADPbS. The data in
Figure 1 therefore indicate that RNase activity and
OD500 provide reliable readouts for Ire1KR32 oligomeri-
zation and support the model [8] in which oligomeriza-
tion and RNase activation are mechanistically coupled.
Activation of Ire1 RNase by different cofactors
To quantitatively define the potency of different Ire1
cofactors, we measured the activation of Ire1KR32
RNase in vitro following the site-specific cleavage of a
32P-labeled RNA hairpin substrate. We found that at
saturating concentrations, nucleotides AMP and ATP
both activated Ire1KR32 by approximately tenfold (Fig-
ures 2a and 2b). Notably, although the effects at satura-
tion were similar, the apparent affinity for AMP was
tenfold lower than that observed for ATP (Figure 2c).
By contrast, ADP bound with an apparent affinity simi-
lar to that of ATP, but ADP binding resulted in 20-fold
stronger activation of the enzyme (Figures 2b and 2c).
Among other nucleotides tested, only 2’-deoxy(ADP) sti-
mulated Ire1KR32 RNase comparably to ADP (Figure
2b), although it bound more weakly (Figure 2c). The
divergence of the apparent cofactor binding constants
and maximal stimulation of RNase activity at saturating
cofactor concentrations extended to other cofactors
(Figures 2b and 2c). Thus, surprisingly, cofactor binding
and cofactor-induced conformational changes that pro-
mote Ire1 oligomerization can be experimentally
uncoupled. As binding of the larger ATP molecule fails
to activate Ire1KR32 to the same extent as does binding
of ADP, resulting in an order-of-magnitude smaller
response (Figure 2a), we concluded that mere occupancy
of the ATP pocket does not effect optimal Ire1KR32
activation.
To describe different cofactors quantitatively, we
defined a “potency of cofactor” (Pcof)
Pcof =
kobs
Ire1•cofactor
kobs
apo - Ire1
as the ratio of the kobs of Ire1 with saturating amounts
of cofactor bound over the kobs of apo-Ire1, both mea-
sured under standard assay conditions, which we
defined as 3 μmol Ire1KR32. At this Ire1KR32 concen-
tration, maximum fold stimulation by ADP was achieved
(Figure 1a, dashed line; see also [8]). The relationship
between the macroscopic conformational parameter Pcof
and the microscopic equilibria involved in oligomeriza-
tion is described in the Discussion section and in greater
detail in Additional file 1, Supplementary Analysis 1.
When cofactors are compared using the Pcof metric,
the RNase activity of apo-Ire1 defines the baseline with
Pcof = 1. The presence of bound ADP stimulates
Ire1KR32 strongly with Pcof approximately 200), whereas
the presence of bound AMP or ATP is less effective
(Pcof approximately 10) (Figure 2b). Similarly, synthetic
small molecules that bind to the nucleotide-binding
pocket in Ire1 (Additional file 1, Figure S4) can be
described by Pcof (Figures 2b and 2c). Sunitinib, an
ATP-mimicking drug developed as a competitive inhibi-
tor of EGFR kinase, activated Ire1KR32 to a similar
extent as AMP and ATP (Pcof approximately 30),
whereas APY24 and APY29 activated Ire1 as well as or
better than ADP (Pcof approximately 200 to 300) (Figure
2b) [8].
A b-phosphate-coordinated metal ion facilitates Ire1
oligomerization
Strikingly, the close ADP-mimic ADPbS did not activate
Ire1KR32 (Figure 2b; Pcof approximately 1; ADPbS con-
tains a sulfur atom that replaces a nonbridging oxygen
atom on the b-phosphate, Figure 3a). This finding was
paradoxical because ADPbS bound to Ire1 with the
same affinity as ADP and ATP, as indicated by its
apparent Ki in a competitive inhibition assay of
Ire1KR32’s ADP-stimulated RNase (Figure 2d) and by
measurements of the small RNase stimulation by
ADPbS in the absence of ADP (Figure 2c). Thus we
conclude that the ATP pocket can be occupied by a
tightly binding cofactor without activating RNase.
The sulfur substitution in ADPbS introduces a “soft”
atom, which has a larger covalent radius than that of
oxygen. Sulfur does not form strong hydrogen bonds
and does not coordinate strongly with “hard” cations
such as magnesium [21,22]. Elegant “metal specificity
switch and rescue” experiments that are well established
for ribozymes showed that metal ion coordination dis-
rupted as a result of oxygen-sulfur substitutions can
sometimes be restored if a softer metal cation such as
Mn2+ is supplied to the reaction [21,22]. Indeed, when
we added Mn2+ to the assay buffer, we observed com-
plete restoration of ADPbS cofactor activity to the level
of ADP Mg (Figure 3b; Pcof approximately 100).
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The rescue was specific for a sulfur-soft metal ion
pair because ADPbS did not activate Ire1 by more
than a few fold in the presence of Mg2+ (Figure 3b)
and because Cd2+, another thiophilic metal, also res-
cued the activity (Additional file 1, Figure S5; Pcof
approximately 30). Furthermore, neither Mn2+ nor Cd2
+ stimulated reactions with oxo-ADP (Figure 3c; Addi-
tional file 1, Figure S5). These data strongly point to a
functional connectivity between the b-phosphate of
ADP, Mg2+ ion coordination and a conformational
change in the Ire1 kinase domain, resulting in activa-
tion of Ire1 RNase.
By contrast, such connectivity was not observed for
the g-phosphate of ATP, which also contacts the Mg2+
ion in crystal structures of protein kinases. ATPgS
bound to Ire1 slightly more weakly than ATP (Figure
2c), but at saturation it functioned indistinguishably
from ATP (Figure 2b; Pcof approximately 10 for ATP
and ATPgS).
As expected, RNase activation by ADPbS and Mn2+
fully coincided with Ire1KR32 oligomerization moni-
tored as OD500. Samples of Ire1KR32 were transparent
in the absence of cofactors or in the presence of ADPbS
or Mn2+ alone. By contrast, white oligomer solutions
Figure 2 Allosteric activation of Ire1 RNase by ligands binding to the kinase domain. (a) Activation of Ire1KR32 by AMP, ADP and ATP.
The kobs values of RNase activity were determined as a function of nucleotide Mg
2+ concentration (see Methods). (b) and (c) Characterization of
Ire1 activity with a panel of nucleotides and synthetic ligands. Maximum Ire1 RNase stimulation achieved with cofactors at saturation (b) and
apparent cofactor binding constants (c) are shown. The scale of cofactor potency (Pcof) is indicated in (b). SUNT = sunitinib. Cofactor structures
are shown in Additional file 1, Figure S4. (d) Measurement of binding constants for ADPbS and ATP via inhibition of a reaction stimulated with
0.2 mmol ADP. Ki values of 0.20 ± 0.07 mmol and 0.10 ± 0.04 mmol were determined for ADPbS and ATP, respectively. The data were fit to the
binding isotherm and corrected for the 0.2 mmol ADP background. All reactions contained 3 μmol Ire1KR32 and 2 mmol Mg2+. Error bars show
standard errors of binding isotherm fitting.
Korennykh et al. BMC Biology 2011, 9:48
http://www.biomedcentral.com/1741-7007/9/48
Page 5 of 16
Figure 3 Manganese rescue of Ire1 RNase activity and oligomerization in the presence of ADPbS. (a) Structures of ADP and ADPbS. (b)
and (c) The effect of increasing Mg2+ and Mn2+ concentrations on Ire1 RNase activity in the presence of 2 mmol ADPbS (b) or 2 mmol ADP (c).
The buffer contained 0.2 mmol Mg2+. All reactions contained 3 μmol Ire1KR32. Assays were conducted as described in Figure 1(a)a. (d) Visible
oligomerization of Ire1KR32 in the absence of cofactors and in the presence of 1 mmol ADP, 1 mmol ADPbS, 1 mmol Mn2+ and 1 mmol ADPbS
+ 1 mmol Mn2+. Assays contained 10 μmol Ire1KR32 and were conducted as described in Figure 1(b). All reactions contained 2 mmol Mg2+. The
bar chart below the image shows relative opacity of each sample. (e) Cooperative activation of Ire1KR32 RNase assayed using 32P-5’-HP21
substrate as described in Figure 1(a). Reactions contained 2 mmol ADPbS, 2 mmol Mg2+ and either 0 or 2 mmol Mn2+ as indicated. (f) OD500
versus concentration of Ire1KR32 in the presence of 2 mmol ADP, 2 mmol ADPbS and 2 mmol ADPbS + 2 mmol Mn2+. All reactions contained 2
mmol Mg2+. (g) Interactions involving the b-phosphate in the Ire1 ADP Mg complex (PDB ID 2rio). Note that all three nonbridging oxygen
atoms of the b-phosphate form contacts to either protein residues or Mg2+. (h) The rate constants for Ire1 and Ire1(D828A) in the presence of
ADP Mg2+ and APY29. Error bars show standard errors of single-exponential fitting of corresponding time courses.
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formed in the presence of ADP + Mg2+ or ADPbS +
Mn2+ (Figure 3d; 2 mmol magnesium background was
present in all reactions shown). Measuring RNase activ-
ity and OD500 as a function of Ire1KR32 concentration
further confirmed that ADPbS-saturated Ire1KR32
behaved similarly to apo-Ire1KR32. Upon addition of
Mn2+, cooperative activation profiles with ADPbS
became indistinguishable from those obtained with
Ire1KR32 and oxo-ADP Mg (Figures 3e and 3f).
Because the b-phosphate can rotate around the a-b
bridging bond, replacement of one b-oxygen atom by
sulfur leaves two more oxygen atoms on the b-phos-
phate available for coordination of Mg2+. The deleter-
ious effect of the oxygen-to-sulfur substitution in
ADPbS therefore implies that all three nonbridging oxy-
gen atoms on the b-phosphate form functionally impor-
tant interactions, all of which are required for the
conformational change in Ire1’s kinase domain. Thus,
every nonbridging oxygen atom must obligatorily either
coordinate Mg2+ or form hydrogen-bonding contacts to
the protein. Detrimental effects of the steric bulk intro-
duced by the larger sulfur atom can be disregarded,
because ADPbS works as well as ADP in the presence
of Mn2+.
In the crystal structure of the Ire1 ADP complex (PDB
ID 2rio) [9], nonbridging oxygen 1 (Figure 3g) coordi-
nates to Mg2+, nonbridging oxygen 2 forms a hydrogen
bond through conserved lysine K702 and nonbridging
oxygen 3 forms a hydrogen bond to the backbone of
strand b1 (GXGXXG motif). This network of connectiv-
ity is conserved among protein kinases [23], suggesting
that lessons learned from the nucleotide effects on Ire1
may be broadly applicable to other protein kinases.
In Ire1, the b-phosphate-coordinating Mg2+ ion addi-
tionally coordinates to the conserved aspartate D828,
which is functionally important for Ire1 RNase activa-
tion (Figures 3g and 3h). As shown in Figure 3h,
removal of this interaction via a D828A mutation in
Ire1KR32 results in a loss of Ire1 responsiveness to ADP
Mg, consistent with the importance of the magnesium
coordination demonstrated by the studies of ADPbS
above. Addition of the magnesium-independent cofactor
APY29 [8] (Figure 2b and Additional file 1, Figure S4),
which replaces the b-phosphate-magnesium moiety with
an aromatic ring, partially activated Ire1KR32(D828A)
(Pcof approximately 10; Figure 3h). Therefore, the
Ire1KR32(D828A) mutant retains the intrinsic ability to
become activated by cofactors, and the loss of respon-
siveness to ADP Mg2+ arises, at least partially, from the
impaired magnesium coordination.
On the basis of the data presented so far, we con-
clude that the b-phosphate-interactions of ADP with
Ire1 kinase form a “b-phosphate latch”. This latch
involves a centrally positioned Mg2+ ion that lies at the
core of the molecular switch that controls Ire1 oligo-
merization and thereby its RNase activity. For natural
adenosine nucleotides, this latch is engaged via a
highly specific hydrogen bonding and metal coordina-
tion network. For synthetic ligands, such as APY29,
the b-phosphate latch is bypassed by metal-indepen-
dent interactions such as hydrophobic and/or hydro-
gen-bonding contacts.
The position of the b-phosphate is dynamically linked to
the conformation of the kinase domain
Equivalently placed cofactor-bound Mg2+ ions are found
in other protein kinases that are structurally similar to
Ire1 [9,11-17], including the closely related and structu-
rally well-characterized cell cycle regulator kinase
CDK2. The high structural similarity between CDK2
and Ire1 kinase domains (Additional file 1, Figure S2)
suggests that insights gained from CDK2 may help
increase the understanding of Ire1 function and vice
versa. Comparisons of aligned structures of CDK2 ADP
Mg, CDK2 ATP Mg with and without bound cyclin (a
CDK2 activator) and apo-CDK2 reveal only a minor dis-
placement (root mean square displacement approxi-
mately 1 Å) of the position of the adenosine base
(Figure 4a), yet phosphate atoms of the bound nucleo-
tides move much larger distances. The b-phosphate in
particular stands out as the most rearranged part of the
nucleotides, occupying one of two positions that are 4.8
Å apart. As we discuss below, these two states of the
nucleotide and the kinase domain are linked to the rear-
rangement of the aC-helix common to protein kinases
and are indicative of switching CDK2 between its inac-
tive (aC-helix “out”, E51 points outside the ATP pocket)
and active (aC-helix “in”, E51 points inside the ATP
pocket) conformations (Figure 4b) [12]. The same con-
nection between the b-phosphate position and the
kinase conformation could be established for a well-
characterized tyrosine kinase cSrc that also has been
crystallized in several conformations (Additional file 1,
Figure S1a).
Two relevant conclusions arise from published crystal
structures of protein kinases. First, ATP can bind to a
kinase domain without noticeably altering its inactive
conformation, as judged by the unchanged position of
the aC-helix in apo-CDK2 and in CDK2 ATP Mg com-
plexes (Figures 4b and 4c). Therefore, in agreement with
our studies on Ire1KR32 and ADPbS, conformational
changes in the kinase domain do not necessarily occur
in response to occupancy of the nucleotide binding
pocket. Second, transition from the inactive to the active
conformation upon the binding of cyclin to CDK2 ATP
results in a pronounced (approximately 10 Å) movement
of the aC-helix (Figure 4b, 1), demarcating its switch to
the active conformation [12], and in an approximately
Korennykh et al. BMC Biology 2011, 9:48
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5-Å movement of the b-phosphate (Figure 4b, 2). This
global conformational rearrangement positions a con-
served glutamate E51CDK2 to interact through a salt
bridge with the conserved lysine K33CDK2, which docks
to the b-phosphate. The docking of the b-phosphate
aligns the g-phosphate in the proper geometry for phos-
photransfer [24] (Figure 4b, 2).
Our experiments demonstrating the rescue of
Ire1KR32 ADPbS activity by Mn2+ suggest that b-phos-
phate insertion does not occur merely in response to a
conformational change in the kinase domain. Instead, it
supplies appreciable free energy for stabilizing Ire1
kinase and, by extension, other related protein kinases
in the active conformation with the aC-helix in the “in”
orientation.
The movement involving aC-helix is a dynamic fea-
ture of many protein kinases [12,14,25]. Important to
the work presented here is that the residues for b-
phosphate placement in CDK2 (E51 and K33) are con-
served in Ire1 (E715 and K702, respectively). To assess
experimentally whether the aC-helix in Ire1 functions
in the conformational switch, we probed the predicted
salt bridge K702-E715 by mutagenesis. Because K702 is
also directly involved in cofactor binding (Figure 4b),
we judged that the effects of any K702 mutations
could not be interpreted straightforwardly and there-
fore focused the mutagenesis on E715. We chose to
mutate E715 to lysine, creating Ire1KR32(E715K), to
minimize perturbations to space filling, local hydro-
phobicity and H-bonding capability. The E715K muta-
tion introduces a repulsive electrostatic interaction
with K702 and is expected to destabilize the aC-helix
“in” conformation.
In agreement with this expectation, the Ire1KR32
(E715K) mutant displayed a vastly decreased RNase
activity (Figure 1c, triangles) and did not oligomerize
at concentrations at which wild-type Ire1KR32 pro-
duced large amounts of oligomers (Figure 1d, triangles
versus squares). As the mutational perturbation of aC-
helix was expected to affect the phosphotransfer activ-
ity of the Ire1 kinase, it was important to rule out that
the oligomerization defect of the Ire1KR32(E715K)
mutant and its concomitant loss of RNase activity did
not result solely from a loss of phosphorylation. The
effect of the loss of phosphorylation could be evaluated
readily by comparing Ire1KR32(E715K) with Ire1KR32,
which would be entirely unphosphorylated. To this
end, we used the double-mutant Ire1KR32(D797N,
K799N), which has a catalytically inactive kinase
domain, purifies with no phosphates attached and
retains readily detectable RNase activity [20]. At con-
centrations that allowed Ire1KR32(D797N, K799N) to
oligomerize nearly to the level of wild-type Ire1KR32
and to exhibit nearly maximal RNase activity,
Ire1KR32(E715K) showed only trace RNase activity
and only trace levels of oligomers in the OD500 read-
out (Figures 1c and 1d). These findings confirm that
the deleterious effects of the E715K mutation cannot
be accounted for even by the complete loss of
b
a
c
Figure 4 Coupled motion of aC-helix and b-phosphate in an
Ire1-like kinase CDK2. (a) ATP bound to CDK2 (orange trace; CDK2
is in the inactive conformation) is, for most of its atoms, well
aligned with ADP and ATP bound to a CDK2 cyclin complex (blue
and green traces, respectively; CDK2 is in the active conformation),
except for the b-phosphate, which is displaced by approximately 4.8
Å. (b) Key conformational rearrangements during inactive ↔ active
transition in CDK2. Movement of aC-helix and E51 (1) is coupled to
the movement of b-phosphate (2). The conformational change
involves formation of a salt bridge between E51 and K33, formation
of an interaction between K33 and b-phosphate and rotation of the
g-phosphate for in-line attack by the OH group of the substrate
(small arrow connecting dashed lines indicates change in geometry)
[41]. Coordinates are from PDB ID: 1hcl (apo-CDK2), 1b39 (ATP-
bound CDK2), 1qmz (ATP-bound CDK2 with cyclin) and 1gy3 (ADP-
bound CDK2 with cyclin). (c) The conformation of the CDK2 kinase
domain in the ATP-bound state (inactive conformation with no
cyclin bound) is similar to the apo-state (inactive conformation with
no cyclin bound) rather than to the ADP-bound state (active
conformation with cyclin bound). A corresponding comparison of
several additional kinases is shown in Additional file 1, Figure S1.
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phosphorylation and therefore support the model that
E715 controls the conformational properties of Ire1.
This model is also supported by the recent crystal
structure of unphosphorylated human Ire1a, which
shows human Ire1a in an inactive conformation. In this
structure, the b-phosphate latch is disengaged, the acti-
vation loop and the aC-helix are in the inactive confor-
mation and the salt bridge K599-E612 (corresponding to
K702-E715 in yeast Ire1) is disrupted [26]. While for-
mally remaining conjecture, it is very likely that the
K599-E612 interaction and the b-phosphate insertion
also occur in the active conformation of human Ire1a,
because the active conformations are essentially the
same for all protein kinases [27]. According to this view,
the functional analyses of Ire1KR32(E715K) presented
herein support the conformational similarity of Ire1,
CDK2, cSrc, EGFR and related protein kinases inferred
from their sequence and structural similarity.
Crystal structure of an Ire1KR32 oligomer with an apo-
kinase domain
The results presented so far suggest a model in which
ADP Mg locks Ire1 into the aC-helix “in” conformation,
which favors oligomerization and thereby activates
RNase. From the principle of coupled equilibria, it fol-
lows that oligomerization, if it can be induced without
kinase ligand binding, would likewise lock the kinase
domain into the active aC-helix “in” conformation.
Indeed, high concentrations of apo-Ire1 induce coopera-
tive oligomerization and activation of RNase, illustrating
the ability of apo-Ire1 to oligomerize without cofactors
(Figures 1a and 1b; see also [8]). Structural insights into
this apo-Ire1 oligomer, however, have been missing
because to date attempts to crystallize the oligomeric
Ire1KR32 in the absence of ATP pocket-binding cofac-
tors have not been successful. In the present study, we
circumvented this problem by introducing a new ligand,
an oligonucleotide bound to the RNase domain, that
resulted in diffracting crystals of IreKR32 in its oligo-
meric state but with a ligand-free apo kinase domain.
To this end, we used a splice-site mimic oligonucleo-
tide (CCGCAG) containing 2’-deoxy substitutions
throughout to prevent its degradation by Ire1. Oligonu-
cleotide-complexed Ire1KR32 crystallized in space group
C222 and diffracted to 6.0 to 6.6 Å (Table 1 and Addi-
tional file 1, Figure S6). The asymmetric unit contained
seven Ire1KR32 molecules. The asymmetric units
packed to form the same oligomeric structure as in the
3.2-Å complex previously crystallized with the small-
molecule activator APY29 in the kinase active site,
which crystallized in space group P21212 and had 14
Ire1KR32 molecules per asymmetric unit (PDB ID 3fbv)
(Figure 5a). The oligomers in C222 and P21212 struc-
tures pack via a different set of crystallographic contacts
(Figure 5a, bottom; note the presence of RNase/RNase
interfilament contacts in the C222 structure but not in
the P21212 structure), strongly supporting the notion
that the Ire1KR32 oligomer is a stable assembly not
resulting from a particular crystal environment. Electron
density for the bound substrate was observed in the
Table 1 Data collection and refinement statisticsa
Data collection and refinement Statistics Subcategory Value
Data collection Cell dimensions Space group C222
a, b, c (Å) 91.67, 580.82, 177.99
a, b, g (°) 90, 90, 90
Resolution (Å) 97-6.60 (6.8-6.60)
I/s(I) 16.62 (1.09)
Rpim
b (%) 4.4 (88.3)
Number of reflections 9402 (766)
Completeness (%) 99.9 (99.9)
Data refinement Number of atoms (in one monomer) Protein 3399
Resolution (Å) 97-6.60
Rigid body (with NCS) Angles (o) 0.925
Bonds (Å) 0.006
Rwork/Rfree 0.2863/0.3170
Simulated annealing (with NCS) t (°K) 1,000
Angles (°) 1.197
Bonds (Å) 0.007
Rwork/Rfree 0.2731/0.3451
aRefinement was done using rigid body protocol. Simulated annealing was not used in final analysis, except for calculations of omit maps. Values for the highest
resolution shell are shown in parentheses. bPrecision-indicating merging R-factor [42].
Definitions: NCS - non-crystallographic symmetry; Rpim - precision-indicating merging factor; Rwork - crystallographic residual factor; Rfree - free crystallographic
residual factor.
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b    
a    
c                                                                          d 
Figure 5 Crystal structure of the Ire1KR32 oligomer obtained without ligands in the ATP pocket. (a) Ire1 kinase/RNase forms an oligomer
with the synthetic ligand APY29 (crystal P21212) and with a 6-mer DNA oligonucleotide that served as a noncleavable mimic of Ire1’s RNA
substrate (crystal C222). The sequence dCdCdGdCdAdG of the oligonucleotide is derived from the splice site of HAC1 mRNA. The filaments in
the P21212 and in the C222 structures pack using entirely different sets of crystal contacts. (b) Simulated annealing (2,000 K) NCS-averaged Fobs -
Fcalc difference map of the twofold symmetric density in the RNase active site (contoured at 5.5 s). (c) Simulated annealing (2,000 K) NCS-
averaged Fobs - Fcalc omit map for the aC-helix (contoured at 5.5 s) and for the activation loop (contoured at 4.5 s) in the C222 structure (red).
Omit maps were calculated with aC-helix and activation loop residues deleted from all seven monomers prior to refinement. Analogous maps
calculated by simulated annealing without NCS restraints are shown in Additional file 1, Figure S7. (d) Superposition of CDK2 and Ire1KR32 in
the apo-bound state (this work) and the ADP-bound state (PDB ID 2rio) shows that the aC-helix of apo-Ire1KR32 (in the C222 structure) occupies
the same conformation as in Ire1 ADP and in CDK2 ADP cyclin complexes, which is distinct from that in the inactive apo-CDK2 structure.
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RNase active site (Figure 5b). Its implications for the
catalysis of RNA cleavage are discussed in a separate
publication [19].
Although at 6.6-Å resolution it is not possible to iden-
tify positions of individual side chains, secondary struc-
tural elements can be resolved, as evidenced by low-
resolution crystal structures of other macromolecules
[28], especially if a high-resolution structure can be used
for phasing. Sevenfold noncrystallographic symmetry
averaging greatly enhanced the effective quality of the
Ire1-oligonucleotide complex density map (Figures 5c
versus Additional file 1, Figure S7). A cross-validated
SigmaA test [29] showed that useful and statistically sig-
nificant diffraction spans to approximately 6.0 Å. The
simulated-annealing omit electron density maps, in
which the model bias for the aC-helix and the activa-
tion loop regions is minimized, demonstrate unambigu-
ously that the aC-helix and the activation loop, the two
most dynamic parts of kinases, are in the same position
as they were in two previous structures, in which either
ADP Mg or the synthetic activator APY29 was bound
(PDB ID 2rio[9] and PDB ID 3fbv[8]) (Figures 5c and
5d and Additional file 1, Figure S7). These observations
are in agreement with the model that oligomerization of
apo-Ire1KR32 requires the aC-helix to be in the “in”
position. On the basis of these findings, it is likely that
oligomerization plays the same role in controlling Ire1
conformation as cyclin binding does in CDK2 and
dimerization does in EGFR [12], such that binding of a
protein partner stabilizes the aC-helix in the “in” posi-
tion, even when the kinase active site is empty.
Discussion
Protein kinases are dynamic enzymes that couple cataly-
sis to pronounced conformational changes. Studies of
their dynamics are limited by the intrinsic difficulty of
uncoupling enzymatic phosphoryl transfer from confor-
mational properties. In the present study, we exploited
the unique facets of Ire1 biology to overcome this short-
coming. The approach was made possible by Ire1’s
unique property to form easily quantified high-order
homo-oligomers upon activation and by Ire1’s RNase
domain, which provides a natural built-in reporter of
the kinase domain conformation. Conformational
changes in Ire1’s kinase domain modulate the enzyme’s
predisposition to form oligomers, in which Ire1-Ire1
contacts across multiple interfaces activate Ire1’s RNase
activity.
The propensity of Ire1 for activation is modulated by
three parameters: (1) its local concentration, (2) its
phosphorylation state and (3) its interactions with cofac-
tors in the ATP binding site of Ire1’s kinase module. In
its physiological setting, the local concentration of the
cytoplasmic Ire1 kinase/RNase module is responsive to
the protein-folding conditions inside the ER lumen. As
unfolded proteins accumulate there, the Ire1’s luminal
domain oligomerizes, thereby concentrating the cova-
lently tethered kinase/RNase domains on the other side
of the membrane. This concentration event is thought
to provide the primary switch leading to Ire1 activation.
In this view, trans-autophosphorylation would ensue fol-
lowing juxtaposition of the kinase domains. The phos-
phorylation state of Ire1 is a dynamic parameter that
changes over time and is thought to contribute to a
molecular timer. Initial phosphorylation events on the
activation loop lead to phosphorylated side chains that
form stabilizing salt bridges to neighboring Ire1 mole-
cules in the active oligomer [8], whereas subsequent
hyperphosphorylation events appear to promote Ire1
turnoff, perhaps because of oligomer-destabilizing
charge repulsion effects [20].
Cofactor binding to the ATP pocket of the kinase
domain is expected to provide another regulatory input
that strongly modulates the sensitivity of the switch to
integrate UPR signaling with the physiological state in
the cell’s cytoplasm. In particular, it is intriguing to
speculate that UPR may be modulated by the ADP/
(ATP+AMP) ratio due to the 20-fold higher Pcof of ADP
compared to ATP and AMP. Up to an order of magni-
tude change in the ADP/ATP ratio has been reported
during glucose starvation in pancreatic b cells and dur-
ing apoptosis [30,31]. If this were also the case during
the UPR, an increase in the relative ADP level would
sensitize Ire1, requiring lower concentrations of
unfolded proteins to activate the UPR. An alternative
possibility could be that an unknown stress-induced
small-molecule metabolite with high Pcof and low Kcof,
other than nucleotides, could serve biological roles in
modulating Ire1 activity via binding in the ATP pocket.
Work in mammalian systems suggests that Ire1 can be
activated independently of an accumulation of unfolded
proteins in the ER lumen, perhaps by utilizing such a
mechanism to shift the oligomerization activation
threshold [32]. It has been shown that, in addition to
the ATP pocket, Ire1 has a different pocket in the
RNase domain and that binding of quercetin to this
pocket stimulates Ire1 RNase [33]. This finding opens
up a possibility that, in addition to the kinase-binding
ligands, ligands binding to the RNase domain of Ire1
contribute to modulation of Ire1 signaling.
Phosphorylation of Ire1 considerably affects its
responsiveness to cofactors. In the presence of ADP,
fully phosphorylated Ire1KR32 exhibits a 40-fold stron-
ger Pcof (approximately 200) compared to Ire1KR32
(D797N, K799N) lacking phosphates (Pcof approximately
5) (data not shown). Therefore, phosphorylation not
only promotes Ire1 oligomerization but also “primes”
the receptor for sensing ATP pocket-binding cofactors.
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Notably, unlike Pcof, binding of cofactors to Ire1 does
not appear to depend on Ire1 phosphorylation, as both
Ire1KR32 and Ire1KR32(D797N, K799N) exhibit similar
Kcof values with ADP (data not shown). The effect of
phosphorylation on Ire1 sensitivity to cofactors has also
been observed during the study of the quercetin pocket
[33]. These observations suggest that modulation of Ire1
signaling by cofactors may be physiologically most
important after the UPR has been initiated, amplifying
the activity of Ire1 molecules that have already been
phosphorylated.
By measuring the Ire1 RNase activity in response to
kinase-bound small molecules, we resolved two indepen-
dent steps in cofactor-Ire1 interactions: cofactor binding
and the conformational response to a bound cofactor.
Noting the wide spectrum of potencies of different
cofactors at saturation, Pcof, we propose a simple model
in which cofactors bound in the ATP pocket shift an
equilibrium between an inactive and an active confor-
mation of Ire1 (Figure 6). In the model, the inactive
conformation “O” corresponds to that of a free Ire1
monomer that has the aC-helix in the inactive, “out”
position also observed for other protein kinases. The
active conformation “I” corresponds to that of Ire1 oli-
gomers with the aC-helix in the active, “in” position.
The conformational equilibrium between the “O” and
“I” states depends strongly on the chemical nature of
the bound cofactor. Whereas some cofactors, such as
ADPbS, bind without noticeably perturbing this equili-
brium, other natural and synthetic cofactors effect an
equilibrium shift of over two orders of magnitude. The
effect of the cofactors on the oligomerization equilibria
(Figures 6a versus 6b) is summarized in the free energy
diagram shown in Figure 6c. According to our model
shown in Figure 6c, cofactors lower the free energy of
the “monomer I” state (compare the “monomer I” states
on the solid and the dashed lines), ultimately resulting
in an equilibrium shift toward oligomerization (compare
the “oligomer I” states on the solid and the dashed
lines).
Quantitative manifestations of the two steps, apparent
cofactor affinity Kcof and cofactor potency Pcof, do not
correlate (Figure 2b vs. Figure 2c), suggesting that they
arise from distinct (perhaps partially overlapping) sub-
sets of molecular interactions. The ADP/ADPbS com-
parison (Figure 2) indicates that the kinase hinge-
contacting face [8] of the cofactors serves for binding,
whereas the K702/E715-contacting face (Figure 4b and
Additional file 1 Figure S4) modulates the kinase con-
formation and could be exploited for designing potent
synthetic Ire1 activators. Our findings show that Ire1, as
already known for other protein kinases, can exist with
the ATP pocket filled by cofactors while remaining in
the inactive conformation. With certain cofactors such
as ADPbS, this functional state could dominate in solu-
tion, a notion previously unappreciated in studies of
Ire1.
The macroscopically measured parameters Kcof and
Pcof are composite derivatives of the microscopic con-
stants K1d , K
2
d and K
oligomer
d
. (Figure 6 and Additional
file 1, Supplementary Analysis 1). The Kcof value
depends largely on (and is equal to, when K2d is large)
the true microscopic binding constant K1d . The Pcof
value depends only on K2d and K
oligomer
d
and not on the
binding constant K1d . Therefore, Pcof is indeed a quanti-
tative metric of conformational responsiveness to bound
cofactor, uncoupled from the cofactor binding step, and
describes the apparent pressure pushing the kinase
domain toward the active conformation with the aC-
helix “in” position. For ADP, Pcof arises predominantly
because of the b-phosphate-magnesium insertion into
the kinase domain (b-phosphate latch), which is func-
tionally defined herein using the metal specificity switch
approach.
Synthetic molecules lacking a b-phosphate equivalent
altogether can achieve the same goal in the absence of
Mg2+ ions by inserting bulky moieties in the b-phos-
phate position. In agreement with this model, sunitinib
(Additional file 1, Figure S4), which is predicted to
occupy the b-phosphate position only partially [8], has a
relatively low Pcof (approximately 30) (Figure 2b).
In CDK2, productive docking of the ATP b-phosphate
in the latched position is facilitated by an external effec-
tor, cyclin, that stabilizes the aC-helix “in” conformation
extrinsically [12]. A conceptually similar mechanism is
employed by EGFR, which dimerizes using one EGFR
monomer to stabilize another EGFR monomer in the
aC-helix “in” conformation [12]. Ire1 does not require a
cyclin equivalent, but instead uses homo-oligomerization
to stabilize the aC-helix “in” conformation.
Conclusions
We have characterized an allosteric mechanism by
which cofactor binding to the ATP pocket of the Ire1
kinase domain activates the receptor’s RNase domain.
Our studies of Ire1KR32(E715K) demonstrate that the
K702-E715 salt bridge is important for aC-helix posi-
tioning and Ire1 activation. In combination, the struc-
tural rearrangements in CDK2 (Figure 4) and the
presented functional and structural observations with
Ire1 converge on a model in which predisposition
toward the active conformation of the kinase domain
(defined by the position of the aC-helix) is tightly
coupled to b-phosphate docking of bound nucleotide (a
b-phosphate latch). Suboptimal b-phosphate docking, as
in Ire1 ADPbS, Ire1 ATP Mg or CDK2 ATP Mg, does
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not preclude the nucleotide from binding, but results in
the predominantly inactive conformation and, for Ire1, a
correspondingly low Pcof value.
For CDK2, Ire1, cSrc, EGFR and perhaps numerous
other protein kinases that use aC-helix movement for
conformational control, interactions with bound ligands
in the ATP pocket may be strongly allosterically coupled
to the inactive ↔ active transition and may influence
the surface where these kinases bind external effectors.
For Ire1, cofactors produce an orders of magnitude shift
in the oligomer population, demonstrating that ligands
can drive protein-protein interactions involving the
kinase/RNase module of Ire1. Analogously, cofactor-
mediated conformational tuning of protein kinases
related to Ire1 might be deployed to recruit their bind-
ing partners and allow protein kinases and catalytically
Figure 6 Model of cofactor action during Ire1 oligomerization and activation. (a) Two-step model for oligomerization and activation of
apo-Ire1. (b) Three-step model for cofactor-stimulated Ire1 activation involving equilibrium of two distinct cofactor-bound Ire1 species. The
macroscopic parameter Pcof depends on the ratio of cofactor-bound Ire1 populations in “inactive” conformation (marked as “O”, which
designates the aC-helix in the “out” position seen in the inactive conformation of CDK2) and in “active” conformation required for the oligomer
assembly (marked as “I”, which designates the aC-helix in the “in” position seen in the active conformation of CDK2). The macroscopic apparent
cofactor binding constant Kcof depends on the elementary constants K1d and K
2
d , whereas the cofactor potency Pcof depends on the K
2
d and
Koligomerd (Additional file 1, Supplementary Analysis 1). (c) Schematic free-energy diagram for the cofactor-independent and the cofactor-facilitated
Ire1 oligomerization that corresponds to the schemes shown in (a) and (b). The shift in the oligomerization equilibrium arises from the
stabilization of monomer “I” by cofactors.
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inactive pseudokinases encoded in metazoan genomes to
function as signaling conformational switches indepen-
dent from ATP hydrolysis. The paradoxical in-trans-
activation of RAF kinase and extracellular signal-regu-
lated kinase by kinase inhibitors [34,35] apparently
arises from such a mechanism.
Methods
Experimental errors
Observed rate constants were always determined from
reaction time courses. Kinetic parameters were repro-
duced two or more times and had day-to-day variability
typically within twofold. This uncertainty is small com-
pared to all effects presented in this work as significant.
Errors and experimental uncertainties are indicated
where applicable.
Ire1 expression and purification
Ire1KR32 and its mutants were expressed as glutathione
S-transferase (GST) fusion proteins using pGEX-6P-2
plasmid (GE Healthcare, Waukesha, WI) and codon-
compensated E. coli (BL21-CodonPlus(DE3)-RIPL Com-
petent Cells; Stratagene, Santa Clara, CA) as described
previously [8]. In brief, expression was performed at
room temperature for four hours after isopropyl-b-D-
thiogalactopyranoside induction. Cells were lysed using
the EmulsiFlex-C3 homogenizer (Avestin Inc. Ottawa,
Ontario, Canada) and proteins were purified by per-
forming an affinity column chromatography with subse-
quent cleavage of the GST tag by using PreScission
Protease (GE Healthcare, Waukesha, WI). All protein
mutants were fractionated by gel filtration on an S200
column (GE Healthcare, Waukesha, WI) to approxi-
mately 99% purity. Proteins stocks (10 to 20 mg/mL)
were stored at -80°C in the presence of 5% glycerol.
RNA substrates
RNA oligonucleotides were purchased from Dharmacon
Inc. (Lafayette, CO), labeled at the 5’-terminus using T4
polynucleotide kinase and 32P-ATP (PerkinElmer-NEN,
Waltham MA) and purified by 20% PAGE that allowed
single-nucleotide resolution as described previously [8].
Ire1 RNase cleavage assay
The kinetics of RNA cleavage were assessed as described
previously [8]. Typically, reactions were carried out in a
10-μL volume at 30°C. Reactions were started by adding
1 μL of 32P-labeled RNA to 9 μL of premixture contain-
ing 20 mmol 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid (HEPES), pH 7.4, 70 mmol NaCl, 2 mmol
MgCl2 (unless indicated otherwise), 4 mmol dithiothrei-
tol (DTT), 5% glycerol and cofactors as indicated. The
reactions contained ≤ 1 pmol radioactively 32P-labeled
RNA and were conducted under single-turnover
conditions. Unless noted otherwise, the Ire1 concentra-
tion was 3 μmol. The enzyme concentration was deter-
mined from the Ire1KR32 sequence by using absorbance
at 280 nm (e280 = 40.8 × 10
3 mol-1cm-1) calculated
using the Electronic Lab Notebook program http://bio-
chemlabsolutions.com/ELN/ELN.html. Reactions were
quenched at time intervals with 6 μL of stop solution
containing 10 mol urea, 0.1% SDS, 0.1 mmol ethylene-
diaminetetraacetic acid, 0.05% xylene cyanol and 0.05%
bromophenol blue. Samples were analyzed by perform-
ing 10% to 20% PAGE, and gels were scanned using the
Typhoon 9400 scanner (Molecular Dynamics-GE
Healthcare, Waukesha, WI) and quantified using Image-
Quant image analysis software (Molecular Dynamics-GE
Healthcare, Waukesha, WI and GelQuant.NET software
http://biochemlabsolutions.com/GelQuantNET.html.
The data were plotted and fit in SigmaPlot software
(Systat Software Inc., Chicago, IL) to exponential curves
to determine observed rate constants and to hyperbolic
curves to determine binding constants.
Optical assay of Ire1 oligomerization
Ire1KR32 oligomerization was assayed in a reaction buf-
fer containing 20 mmol HEPES, pH 7.4, 70 mmol NaCl,
2 mmol MgCl2, 4 mmol DTT and 5% glycerol. Cofac-
tors and Mn(CH3COO)2 were added as indicated for
each experiment. The transparency of the samples con-
taining higher concentrations of Ire1 visibly changed
immediately upon adding the enzyme. Samples were
allowed to sit for 15 minutes to allow for complete Ire1
oligomerization. The OD of the samples was then mea-
sured at room temperature (22°C) at 500 nm on a UV-
visible spectrophotometer (Amersham Ultrospec 3300
Pro; Amersham-GE Healthcare, Waukesha, WI). OD500
was obtained after subtraction of baseline absorbance
from the buffer free of Ire1. Sample absorbance did not
change upon repeated scans of the same sample, indi-
cating that the oligomerization had reached equilibrium
under the conditions of the experiments.
The oligomer of Ire1KR32 has a uniform absorbance
over 300 to 800 nm, exhibiting higher absorbance at
shorter wavelengths. We selected l = 500 nm for practical
considerations, because at this wavelength proteins do not
absorb light and the relevant range of Ire1KR32 concen-
trations (0.1 to 10 μmol) produces a signal within the opti-
mal instrument range (0.01 to 1 OD). The same titration
profiles were obtained not only by reading OD but also by
measuring light scattering at a 90° angle at excitation and
emission wavelengths of 500 nm on a FluoroLog-3 fluo-
rometer (HORIBA Jobin Yvon, Edison, NJ).
Ire1KR32 (dCdCdGdCdAdG) complex crystallization
The Ire1KR32 (dCdCdGdCdAdG complex was prepared
by mixing Ire1KR32 and dCdCdGdCdAdG (Integrated
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DNA Technologies, Coralville, IA). When performed at
a relatively low NaCl concentration (300 mmol or less),
addition of the oligonucleotide caused profound precipi-
tation of the oligomeric complex, as observed upon the
addition of ADP Mg [8]. The oligonucleotide thus
apparently promoted the formation of Ire1KR32 oligo-
mers analogous to ADP Mg and to APY29. The precipi-
tate readily redissolved upon a slight increase in NaCl
concentration, indicating that the oligomerization reac-
tion was salt-dependent and readily reversible. Crystalli-
zation was conducted in hanging drops using a stock
solution of a premade complex containing Ire1KR32 (12
mg/mL) and 0.6 mmol 2’-deoxy-CCGCAG. The well
solution contained 0.12 mol sodium citrate (pH 6.5), 7%
PEG 3350 and 4% glucose. Single crystals grew over-
night and were cryoprotected in a well solution contain-
ing 25% ethylene glycol. The crystals belong to
orthorhombic space group C222, distinct from the
orthorhombic space group P21212 previously reported
for Ire1KR32 oligomer with bound APY29. Crystalliza-
tion of a variety of other nucleotides and protein con-
structs was also tested but produced either inferior
crystals or no crystals.
X-ray data collection and analysis
Diffraction from Ire1 (2’-deoxy-CCGCAG) crystals was
collected on Beamline 8.3.1 (Advanced Light Source,
Lawrence Berkeley National Laboratory, Berkeley, CA,
USA; http://www-als.lbl.gov/index.php/beamlines/
beamlines-directory/118-831.html at an X-ray wave-
length of 1.115872 Å and an oscillation angle of 1°.
The data were indexed, integrated and scaled using
the XDS X-Ray Detector software package (MPI for
Medical Research, Heidelberg, Germany; http://xds.
mpimf-heidelberg.mpg.de/) [36] (Table 1). Five per-
cent of the reflections were marked as a test set
(Rfree). A molecular replacement solution was found
using Phaser Crystallographic Software [37] starting
from monomer C of PDB ID 3fbv as a search model.
Seven copies of monomer C were found in the asym-
metric unit, and the resulting 7-mer of Ire1KR32 was
used for rigid body refinement in PHENIX software
[38]. Simulated annealing was attempted and, as
expected for 6.6-Å resolution, resulted in an excessive
separation between residual factor Rwork and free resi-
dual factor Rfree (Table 1). Simulated annealing was
therefore used only for calculation of unbiased omit
maps (2,000 K). Fourier sA-weighted [39]Fobs - Fcalc
difference maps were used for interpretation of the
parts of the model missing from the starting structure.
Electron density and structure were analyzed and
graphed in Coot (Crystallographic Object-Oriented
Toolkit) software [40] and PyMOL software http://
www.pymol.org/. The sevenfold non-crystallographic
symmetry (NCS) of the model was used to improve
the local quality of the electron density maps by sym-
metry averaging. However, all elements of Ire1 sec-
ondary structure were clearly visible without NCS.
Coordinates have been deposited into the Protein
Data Bank (PDB:3SDM; http://www.rcsb.org/pdb/
search/structidSearch.do?structureId=3SDM.
Additional material
Additional file 1: Supplementary figures, tables and analyses.
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